IL149628A0 - Antithrombotic compound - Google Patents

Antithrombotic compound

Info

Publication number
IL149628A0
IL149628A0 IL14962800A IL14962800A IL149628A0 IL 149628 A0 IL149628 A0 IL 149628A0 IL 14962800 A IL14962800 A IL 14962800A IL 14962800 A IL14962800 A IL 14962800A IL 149628 A0 IL149628 A0 IL 149628A0
Authority
IL
Israel
Prior art keywords
antithrombotic compound
antithrombotic
compound
Prior art date
Application number
IL14962800A
Other languages
English (en)
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of IL149628A0 publication Critical patent/IL149628A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL14962800A 1999-12-07 2000-12-01 Antithrombotic compound IL149628A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99204172 1999-12-07
PCT/EP2000/012155 WO2001042262A2 (en) 1999-12-07 2000-12-01 Antithrombotic compound

Publications (1)

Publication Number Publication Date
IL149628A0 true IL149628A0 (en) 2002-11-10

Family

ID=8240976

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14962800A IL149628A0 (en) 1999-12-07 2000-12-01 Antithrombotic compound
IL149628A IL149628A (en) 1999-12-07 2002-05-14 Antithrombotic polysulfated pentasaccharides, their preparation and pharmaceutical compositions containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL149628A IL149628A (en) 1999-12-07 2002-05-14 Antithrombotic polysulfated pentasaccharides, their preparation and pharmaceutical compositions containing them

Country Status (23)

Country Link
US (1) US6875755B2 (cs)
EP (1) EP1237897B1 (cs)
JP (1) JP4820517B2 (cs)
KR (1) KR100776607B1 (cs)
CN (1) CN1195767C (cs)
AR (1) AR026726A1 (cs)
AU (1) AU781846B2 (cs)
BR (1) BR0016217A (cs)
CA (1) CA2393042C (cs)
CO (1) CO5251449A1 (cs)
CZ (1) CZ303385B6 (cs)
HK (1) HK1047593A1 (cs)
HU (1) HUP0203471A3 (cs)
IL (2) IL149628A0 (cs)
NO (1) NO323059B1 (cs)
NZ (1) NZ519100A (cs)
PE (1) PE20010935A1 (cs)
PL (1) PL202840B1 (cs)
RU (1) RU2266913C2 (cs)
SK (1) SK287682B6 (cs)
TW (1) TWI289566B (cs)
WO (1) WO2001042262A2 (cs)
ZA (1) ZA200203799B (cs)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1440077B1 (en) * 2001-09-07 2013-05-01 Alchemia Limited Synthetic heparin pentasaccharides
JP4530852B2 (ja) 2002-07-15 2010-08-25 メルク・シャープ・エンド・ドーム・コーポレイション 糖尿病治療のためのピペリジノピリミジンジペプチジルペプチダーゼ阻害剤
JP4491346B2 (ja) 2002-10-07 2010-06-30 メルク・シャープ・エンド・ドーム・コーポレイション 抗糖尿病ベータアミノ複素環ジペプチジルペプチダーゼ阻害剤
BR0315796A (pt) 2002-11-07 2005-09-13 Merck & Co Inc Composto, composição farmacêutica, e, métodos para tratar diabetes, para tratar hiperglicemia, e para tratar obesidade em um mamìfero
CA2512546A1 (en) 2003-01-17 2004-08-05 Merck & Co., Inc. 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
EP1592689A4 (en) 2003-01-31 2008-12-24 Merck & Co Inc 3-AMINO-4-PHENYLBUTANOIC ACID DERIVATIVES AS INHIBITORS OF DIPEPTIDYL PEPTIDASE FOR THE TREATMENT OR PREVENTION OF DIABETES
CN1787823A (zh) 2003-05-14 2006-06-14 麦克公司 作为二肽基肽酶抑制剂用于治疗或预防糖尿病的3－氨基－4－苯基丁酸衍生物
DE602004026440D1 (de) 2003-06-06 2010-05-20 Merck Sharp & Dohme Kondensierte indole als dipeptidyl-peptidase-hemmer zur behandlung oder prävention von diabetes
JP4579239B2 (ja) 2003-06-17 2010-11-10 メルク・シャープ・エンド・ドーム・コーポレイション 糖尿病の治療または予防するためのジペプチジルペプチダーゼ阻害剤としてのシクロヘキシルグリシン誘導体
US7259160B2 (en) 2003-07-31 2007-08-21 Merck & Co., Inc. Hexahydrodiazepinones as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
EP1574516A1 (en) * 2004-03-05 2005-09-14 Sanofi-Aventis Antithrombotic compound
TW200621794A (en) * 2004-10-06 2006-07-01 Akzo Nobel Nv Pulmonary administration of an antithrombotic compound
TWI403334B (zh) * 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
TWI376234B (en) 2005-02-01 2012-11-11 Msd Oss Bv Conjugates of a polypeptide and an oligosaccharide
EP1991271B1 (en) * 2005-10-10 2011-03-09 N.V. Organon Anticoagulant antithrombotic dual inhibitors comprising a biotin label
WO2011073408A2 (en) 2009-12-18 2011-06-23 Endotis Pharma Pharmaceutical oral dosage form containing a synthetic oligosaccharide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4115468A1 (de) * 1991-05-11 1992-11-12 Behringwerke Ag Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien
DE4206858A1 (de) * 1992-03-05 1993-09-09 Behringwerke Ag Glycopeptid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische mittel
FR2704226B1 (fr) * 1993-04-22 1995-07-21 Sanofi Elf 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
NZ264340A (en) * 1993-09-01 1995-04-27 Akzo Nobel Nv Bisconjugate comprising two saccharides and a spacer, use in pharmaceutical compositions
IL126893A (en) * 1997-11-19 2003-05-29 Akzo Nobel Nv Sulfated pentasaccharide derivatives and pharmaceutical compositions containing them
EP1087992B1 (en) * 1998-06-17 2008-08-20 N.V. Organon Antithrombotic compounds

Also Published As

Publication number Publication date
AU2003801A (en) 2001-06-18
JP4820517B2 (ja) 2011-11-24
CZ20021958A3 (cs) 2002-08-14
AU781846B2 (en) 2005-06-16
CA2393042C (en) 2011-06-28
NZ519100A (en) 2004-09-24
NO20022689L (no) 2002-06-06
WO2001042262A3 (en) 2001-12-13
US20030114361A1 (en) 2003-06-19
HUP0203471A2 (hu) 2003-02-28
PE20010935A1 (es) 2001-09-20
PL202840B1 (pl) 2009-07-31
IL149628A (en) 2010-04-29
RU2266913C2 (ru) 2005-12-27
KR100776607B1 (ko) 2007-11-16
NO20022689D0 (no) 2002-06-06
PL355484A1 (en) 2004-05-04
TWI289566B (en) 2007-11-11
ZA200203799B (en) 2003-10-29
CZ303385B6 (cs) 2012-08-29
CO5251449A1 (es) 2003-02-28
WO2001042262A2 (en) 2001-06-14
EP1237897B1 (en) 2015-01-14
HUP0203471A3 (en) 2003-03-28
NO323059B1 (no) 2006-12-27
HK1047593A1 (zh) 2003-02-28
SK7942002A3 (en) 2002-09-10
EP1237897A2 (en) 2002-09-11
CN1407989A (zh) 2003-04-02
CA2393042A1 (en) 2001-06-14
CN1195767C (zh) 2005-04-06
KR20020070988A (ko) 2002-09-11
SK287682B6 (sk) 2011-06-06
AR026726A1 (es) 2003-02-26
BR0016217A (pt) 2002-09-10
US6875755B2 (en) 2005-04-05
JP2003520208A (ja) 2003-07-02

Similar Documents

Publication Publication Date Title
GB2357761B (en) Compounds
IL149628A0 (en) Antithrombotic compound
PL345238A1 (en) Antithrombotic compounds
GB9924797D0 (en) Compound
GB9920919D0 (en) Novel compound
GB9904930D0 (en) Thiazoloindolinone compounds
GB9902399D0 (en) Compounds
GB9908828D0 (en) Compounds
GB9921928D0 (en) Compound
GB0031557D0 (en) Compound
GB9905771D0 (en) Compounds
GB9914342D0 (en) Compound
GB0031563D0 (en) Compound
GB9929255D0 (en) Compound
GB9921929D0 (en) Compound
EP1209240A4 (en) CONNECTION F-15078
GB9924965D0 (en) Compound
GB9926160D0 (en) Antithrombotic agents
GB9929445D0 (en) Compound
GB9915436D0 (en) Compound
GB9917377D0 (en) Compound
PL332995A1 (en) Antithrombotic agent
GB9902935D0 (en) Novel compound
GB9905415D0 (en) Novel compound
GB9903266D0 (en) Compounds